Therapeutic drug monitoring-enabled long-term use of linezolid for the successful treatment of refractory pyogenic spondylodiscitis without development of thrombocytopenia: A case report

2021 ◽  
Author(s):  
Takayuki Daisho ◽  
Keisuke Kagami ◽  
Koujiro Yamazaki ◽  
Nobuhisa Ishiguro ◽  
Tsutomu Endo ◽  
...  
Keyword(s):  
Case Report ◽  
Therapeutic Drug Monitoring ◽  
Successful Treatment ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Pyogenic Spondylodiscitis

Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients

2000 ◽  
Vol 152 (1) ◽  
pp. 80-86 ◽  
Author(s):  
Michael Dettling ◽  
Christoph Sachse ◽  
Jürgen Brockmöller ◽  
Jürgen Schley ◽  
Bruno Müller-Oerlinghausen ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Therapeutic Drug

scholarly journals FP858FIRST REPORT OF THERAPEUTIC DRUG MONITORING OF AZATHIOPRINE IN LONG−TERM RENAL TRANSPLANT SURVIVORS − WHAT IS THE DESIRABLE RANGE TO TARGET?

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii364-iii364
Author(s):  
Jennifer R Joslin ◽  
Paul Blaker ◽  
Oliver Tavabie ◽  
Benjamin White ◽  
Anthony Marinaki ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Therapeutic Drug

scholarly journals Successful and safe long‐term treatment of cerebral aspergillosis with high‐dose voriconazole guided by therapeutic drug monitoring

2018 ◽  
Vol 85 (1) ◽  
pp. 266-269 ◽  
Author(s):  
Pier Giorgio Cojutti ◽  
Maria Merelli ◽  
Lorenzo Allegri ◽  
Giuseppe Damante ◽  
Matteo Bassetti ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Term Treatment ◽  
Therapeutic Drug ◽  
High Dose ◽  
Long Term Treatment

Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease

2015 ◽  
Vol 33 (Suppl. 1) ◽  
pp. 70-77 ◽  
Author(s):  
Filip Baert
Keyword(s):  
Monoclonal Antibodies ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Treatment Guidelines ◽  
Therapeutic Drug ◽  
Serum Concentrations ◽  
Short Term ◽  
Clear Dose Response ◽  
Inflammatory Bowel

In recent years it has become clear that therapeutic drug monitoring can be an important tool to optimize outcome and costs of anti TNF treatment including the subcutaneous and fully human monoclonal antibodies. There is a clear dose response curve between early serum concentrations of all monoclonal antibodies and response both short term and long term. The wide variations in early serum concentrations are insufficiently explained by classic pharmacokinetic factors. Low early concentrations can lead to anti-drug antibody formation and ensuing loss of response. Therapeutic drug monitoring allows to rationalize the current practice of dose optimization and the use of concomitant immunomodulator treatment. However more prospective studies are needed before strong recommendations can enter treatment guidelines.

Long-term efficacy and therapeutic drug monitoring of sertraline in major depression

2003 ◽  
Vol 18 (5) ◽  
pp. 385-388 ◽  
Author(s):  
Massimo C. Mauri ◽  
Alessio Fiorentini ◽  
Giancarlo Cerveri ◽  
Lucia S. Volonteri ◽  
Francesca Regispani ◽  
...  
Keyword(s):  
Major Depression ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Term Efficacy

Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of (R,S)-methadone in clinical samples

2009 ◽  
Vol 877 (23) ◽  
pp. 2301-2307 ◽  
Author(s):  
Nicolas Ansermot ◽  
Serge Rudaz ◽  
Marlyse Brawand-Amey ◽  
Sandrine Fleury-Souverain ◽  
Jean-Luc Veuthey ◽  
...  
Keyword(s):  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Analytical Method ◽  
Clinical Samples ◽  
Therapeutic Drug ◽  
Term Evaluation ◽  
On Line
Sign in / Sign up

Export Citation Format

Share Document